In this episode, we explore how targeted therapy drugs are changing the way liver cancer is treated, offering more precise treatment options for patients with advanced disease.
You’ll learn:
• What targeted therapy is and how it works against liver cancer cells
• How targeted drugs help slow tumor growth and block cancer growth signals
• The difference between tyrosine kinase inhibitors and monoclonal antibodies
• When targeted therapy may be recommended for hepatocellular carcinoma (HCC) and primary liver cancer
• How these treatments can help when surgery or a liver transplant is not possible
• Common side effects, including fatigue, skin changes, and high blood pressure
• The role of clinical trials in developing new targeted therapies
• How targeted therapy may be combined with other liver cancer treatments for better outcomes
Whether you are a patient, caregiver, or simply looking to understand modern liver cancer treatment options, this episode provides a clear overview of how targeted therapies help control disease progression and improve quality of life.
Blog Link: Targeted Therapy Drugs for Liver Cancer: A Complete Guide
Send us Fan Mail
Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.
Author: Dr. CHRISTINA NG VAN TZE
📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.